[(2S)-4-methyl-1-[[(4S)-4-methyl-1,2-dioxo-1-[3-(1,4,5,6-tetrahydrocyclopenta[d]pyrazol-3-ylmethylcarbamoyl)azetidin-1-yl]hexan-3-yl]amino]-1-oxopentan-2-yl]carbamic acid

C25H38N6O6 — CID 138470866

IUPAC[(2S)-4-methyl-1-[[(4S)-4-methyl-1,2-dioxo-1-[3-(1,4,5,6-tetrahydrocyclopenta[d]pyrazol-3-ylmethylcarbamoyl)azetidin-1-yl]hexan-3-yl]amino]-1-oxopentan-2-yl]carbamic acid
SMILESCC[C@H](C)C(NC(=O)[C@H](CC(C)C)NC(=O)O)C(=O)C(=O)N1CC(C(=O)NCc2n[nH]c3c2CCC3)C1
InChIInChI=1S/C25H38N6O6/c1-5-14(4)20(28-23(34)18(9-13(2)3)27-25(36)37)21(32)24(35)31-11-15(12-31)22(33)26-10-19-16-7-6-8-17(16)29-30-19/h13-15,18,20,27H,5-12H2,1-4H3,(H,26,33)(H,28,34)(H,29,30)(H,36,37)/t14-,18-,20?/m0/s1
InChIKeyDAFHCCLSRFNVCZ-KEXXGOCASA-N
MW518.62 g/mol
LogP0.76
Rot. Bonds12

About [(2S)-4-methyl-1-[[(4S)-4-methyl-1,2-dioxo-1-[3-(1,4,5,6-tetrahydrocyclopenta[d]pyrazol-3-ylmethylcarbamoyl)azetidin-1-yl]hexan-3-yl]amino]-1-oxopentan-2-yl]carbamic acid

[(2S)-4-methyl-1-[[(4S)-4-methyl-1,2-dioxo-1-[3-(1,4,5,6-tetrahydrocyclopenta[d]pyrazol-3-ylmethylcarbamoyl)azetidin-1-yl]hexan-3-yl]amino]-1-oxopentan-2-yl]carbamic acid (PubChem CID 138470866) has the molecular formula C25H38N6O6 and a molecular weight of 518.62 g/mol. Its IUPAC name is [(2S)-4-methyl-1-[[(4S)-4-methyl-1,2-dioxo-1-[3-(1,4,5,6-tetrahydrocyclopenta[d]pyrazol-3-ylmethylcarbamoyl)azetidin-1-yl]hexan-3-yl]amino]-1-oxopentan-2-yl]carbamic acid.

Molecular Properties

Compound Name[(2S)-4-methyl-1-[[(4S)-4-methyl-1,2-dioxo-1-[3-(1,4,5,6-tetrahydrocyclopenta[d]pyrazol-3-ylmethylcarbamoyl)azetidin-1-yl]hexan-3-yl]amino]-1-oxopentan-2-yl]carbamic acid
PubChem CID138470866
Molecular FormulaC25H38N6O6
Molecular Weight518.62 g/mol
Exact Mass518.29
IUPAC Name[(2S)-4-methyl-1-[[(4S)-4-methyl-1,2-dioxo-1-[3-(1,4,5,6-tetrahydrocyclopenta[d]pyrazol-3-ylmethylcarbamoyl)azetidin-1-yl]hexan-3-yl]amino]-1-oxopentan-2-yl]carbamic acid
SMILESCC[C@H](C)C(NC(=O)[C@H](CC(C)C)NC(=O)O)C(=O)C(=O)N1CC(C(=O)NCc2n[nH]c3c2CCC3)C1
InChIInChI=1S/C25H38N6O6/c1-5-14(4)20(28-23(34)18(9-13(2)3)27-25(36)37)21(32)24(35)31-11-15(12-31)22(33)26-10-19-16-7-6-8-17(16)29-30-19/h13-15,18,20,27H,5-12H2,1-4H3,(H,26,33)(H,28,34)(H,29,30)(H,36,37)/t14-,18-,20?/m0/s1
InChIKeyDAFHCCLSRFNVCZ-KEXXGOCASA-N
XLogP0.76
TPSA173.59 Ų
H-Bond Donors5
H-Bond Acceptors6
Rotatable Bonds12
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500518.62
LogP ≤ 50.76
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}

Analyze [(2S)-4-methyl-1-[[(4S)-4-methyl-1,2-dioxo-1-[3-(1,4,5,6-tetrahydrocyclopenta[d]pyrazol-3-ylmethylcarbamoyl)azetidin-1-yl]hexan-3-yl]amino]-1-oxopentan-2-yl]carbamic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2S)-4-methyl-1-[[(4S)-4-methyl-1,2-dioxo-1-[3-(1,4,5,6-tetrahydrocyclopenta[d]pyrazol-3-ylmethylcarbamoyl)azetidin-1-yl]hexan-3-yl]amino]-1-oxopentan-2-yl]carbamic acid?
The IUPAC name of [(2S)-4-methyl-1-[[(4S)-4-methyl-1,2-dioxo-1-[3-(1,4,5,6-tetrahydrocyclopenta[d]pyrazol-3-ylmethylcarbamoyl)azetidin-1-yl]hexan-3-yl]amino]-1-oxopentan-2-yl]carbamic acid (CID 138470866) is [(2S)-4-methyl-1-[[(4S)-4-methyl-1,2-dioxo-1-[3-(1,4,5,6-tetrahydrocyclopenta[d]pyrazol-3-ylmethylcarbamoyl)azetidin-1-yl]hexan-3-yl]amino]-1-oxopentan-2-yl]carbamic acid.
What is the SMILES notation for [(2S)-4-methyl-1-[[(4S)-4-methyl-1,2-dioxo-1-[3-(1,4,5,6-tetrahydrocyclopenta[d]pyrazol-3-ylmethylcarbamoyl)azetidin-1-yl]hexan-3-yl]amino]-1-oxopentan-2-yl]carbamic acid?
The canonical SMILES for [(2S)-4-methyl-1-[[(4S)-4-methyl-1,2-dioxo-1-[3-(1,4,5,6-tetrahydrocyclopenta[d]pyrazol-3-ylmethylcarbamoyl)azetidin-1-yl]hexan-3-yl]amino]-1-oxopentan-2-yl]carbamic acid is CC[C@H](C)C(NC(=O)[C@H](CC(C)C)NC(=O)O)C(=O)C(=O)N1CC(C(=O)NCc2n[nH]c3c2CCC3)C1.
What is the InChIKey of [(2S)-4-methyl-1-[[(4S)-4-methyl-1,2-dioxo-1-[3-(1,4,5,6-tetrahydrocyclopenta[d]pyrazol-3-ylmethylcarbamoyl)azetidin-1-yl]hexan-3-yl]amino]-1-oxopentan-2-yl]carbamic acid?
The InChIKey is DAFHCCLSRFNVCZ-KEXXGOCASA-N. The full InChI is InChI=1S/C25H38N6O6/c1-5-14(4)20(28-23(34)18(9-13(2)3)27-25(36)37)21(32)24(35)31-11-15(12-31)22(33)26-10-19-16-7-6-8-17(16)29-30-19/h13-15,18,20,27H,5-12H2,1-4H3,(H,26,33)(H,28,34)(H,29,30)(H,36,37)/t14-,18-,20?/m0/s1.
What are the key properties of [(2S)-4-methyl-1-[[(4S)-4-methyl-1,2-dioxo-1-[3-(1,4,5,6-tetrahydrocyclopenta[d]pyrazol-3-ylmethylcarbamoyl)azetidin-1-yl]hexan-3-yl]amino]-1-oxopentan-2-yl]carbamic acid?
[(2S)-4-methyl-1-[[(4S)-4-methyl-1,2-dioxo-1-[3-(1,4,5,6-tetrahydrocyclopenta[d]pyrazol-3-ylmethylcarbamoyl)azetidin-1-yl]hexan-3-yl]amino]-1-oxopentan-2-yl]carbamic acid has a molecular weight of 518.62 g/mol, XLogP of 0.76, 12 rotatable bonds, 5 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [(2S)-4-methyl-1-[[(4S)-4-methyl-1,2-dioxo-1-[3-(1,4,5,6-tetrahydrocyclopenta[d]pyrazol-3-ylmethylcarbamoyl)azetidin-1-yl]hexan-3-yl]amino]-1-oxopentan-2-yl]carbamic acid is sourced from PubChem (CID 138470866), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).